Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Fumarate hydratase pseudogene 1 (FHP1) is a genetic pseudogene related to the fumarate hydratase (FH) gene. Unlike the true FH gene, which codes for an enzyme in the tricarboxylic acid (Krebs) cycle with important metabolic and disease-related functions, FHP1 does not encode an active protein and does not have known biological or disease-related roles in humans. It is not considered a therapeutic target, biomarker, or safety concern. All known disease associations and drug interactions refer to the functional FH gene, not this pseudogene[1][2][3][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Fumarate hydratase pseudogene 1 (FHP1).